30LBA A Phase 1 dose escalation, safety, and pharmacokinetic study of PF-06650808, an anti-Notch3 antibody drug conjugate, in adult patients with advanced solid tumors
Year: 2015
Type: article
Source: European Journal of Cancer
Authors: L.S. Rosen, R. Wesolowski, B. Gibson, R. Baffa, K.H. Liao, J. Masters, S.Y. Hua, S. Deng, R. Shazer, A.W. Tolcher
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2513237238